BRENTWOOD, Tenn. / May 19, 2025 / Business Wire / Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer.
In this new role, Schoeplein will lead development efforts across Ardent’s existing markets and support the organization’s expansion into new regions. He will be responsible for driving growth across inpatient and outpatient care settings through acquisitions, partnerships and joint ventures. Additionally, he will guide due diligence, market intelligence and integration planning to advance Ardent’s long-term growth strategy.
“We are excited to welcome Chris to Ardent at a pivotal time in our growth journey,” said Ardent Health President and CEO Marty Bonick. “His deep industry experience and strong track record of advising health systems will be instrumental as we pursue new opportunities to scale our consumer-centric platform and extend our unique joint venture model to benefit new partners and communities.”
Schoeplein joins Ardent from Kaufman Hall where he served as senior vice president in the firm’s mergers and acquisitions practice. With nearly two decades of healthcare strategy and development experience, he has built a successful track record helping health systems develop strategic partnerships that advance growth and enhance clinical and financial performance. Schoeplein is a graduate of Saint Louis University and a member of the Healthcare Financial Management Association.
About Ardent Health
Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. For more information, please visit ardenthealth.com.
Last Trade: | US$12.69 |
Daily Change: | 0.16 1.28 |
Daily Volume: | 166,981 |
Market Cap: | US$1.820B |
August 05, 2025 May 06, 2025 March 31, 2025 February 26, 2025 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load